BCHE and Alzheimer disease: Despite decades of research, scientists now have some understanding of the complex interactions between genetic and environmental risk factors in AD, but the only commonly used therapeutic drugs for specific symptoms of AD are four cholinesterase inhibitors and one N-methyl-D-aspartic acid receptor (NMDAR) inhibitor, and these drugs can only provide temporary relief (Shega et al., 2009).